{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:46:15Z","timestamp":1775277975028,"version":"3.50.1"},"reference-count":28,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2026,3,31]]},"DOI":"10.1536\/ihj.25-515","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:10:44Z","timestamp":1774908644000},"page":"156-163","source":"Crossref","is-referenced-by-count":0,"title":["Association between Tubular Injury Biomarkers and Early Renal Injury in Hypertensive Patients"],"prefix":"10.1536","volume":"67","author":[{"given":"Jianhui","family":"Zhang","sequence":"first","affiliation":[{"name":"Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Zhongshan Hospital, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Kuai","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Zhongshan Hospital, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzeng","family":"Zou","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University"},{"name":"Institutes of Biomedical Sciences, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Udani S, Lazich I, Bakris GL. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol 2011; 7: 11-21.","DOI":"10.1038\/nrneph.2010.154"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370: 591-603.","DOI":"10.1016\/S0140-6736(07)61299-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Johansen KL, Chertow GM, Gilbertson DT, <i>et al<\/i>. US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2023; 81: A8-A11.","DOI":"10.1053\/j.ajkd.2022.12.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mennuni S, Rubattu S, Pierelli G, <i>et al<\/i>. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens 2014; 28: 74-9.","DOI":"10.1038\/jhh.2013.55"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hart PD, Bakris GL. Hypertensive nephropathy: prevention and treatment recommendations. Expert Opin Pharmacother 2010; 11: 2675-86.","DOI":"10.1517\/14656566.2010.485612"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wei SY, Wang YX, Zhang QF, <i>et al<\/i>. Multiple Mechanisms are Involved in Salt-Sensitive Hypertension-Induced Renal Injury and Interstitial Fibrosis. Sci Rep 2017; 7: 45952.","DOI":"10.1038\/srep45952"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shankland SJ. The podocyte&apos;s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-47.","DOI":"10.1038\/sj.ki.5000410"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci 2021; 58: 354-68.","DOI":"10.1080\/10408363.2021.1879000"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhang WR, Parikh CR. Biomarkers of Acute and Chronic Kidney Disease. Annu Rev Physiol 2019; 81: 309-33.","DOI":"10.1146\/annurev-physiol-020518-114605"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Delanaye P, Cavalier E, Pottel H. Serum Creatinine: Not So Simple! Nephron 2017; 136: 302-8.","DOI":"10.1159\/000469669"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-30.","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Han WK, Bailly V, Abichandani R, <i>et al<\/i>. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-44.","DOI":"10.1046\/j.1523-1755.2002.00433.x"},{"key":"13","unstructured":"13. Kashani K, Al-Khafaji A, Ardiles T, <i>et al<\/i>. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25."},{"key":"14","unstructured":"14. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol 2019; 16: 182-241."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yokoyama T, Kamijo-Ikemori A, Sugaya T, <i>et al<\/i>. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol 2009; 174: 2096-106.","DOI":"10.2353\/ajpath.2009.080780"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wang Y, Zou Z, Jin J, <i>et al<\/i>. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol 2017; 18: 177.","DOI":"10.1186\/s12882-017-0592-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Greenberg JH, Zappitelli M, Jia Y, <i>et al<\/i>. Biomarkers of AKI Progression after Pediatric Cardiac Surgery. J Am Soc Nephrol 2018; 29: 1549-56.","DOI":"10.1681\/ASN.2017090989"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yang L, Brooks CR, Xiao S, <i>et al<\/i>. KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest 2015; 125: 1620-36.","DOI":"10.1172\/JCI75417"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ko GJ, Grigoryev DN, Linfert D, <i>et al<\/i>. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 2010; 298: F1472-83.","DOI":"10.1152\/ajprenal.00619.2009"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int 2009; 76: 604-13.","DOI":"10.1038\/ki.2009.224"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gunnerson KJ, Shaw AD, Chawla LS, <i>et al<\/i>. TIMP2\u2022IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg 2016; 80: 243-9.","DOI":"10.1097\/TA.0000000000000912"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pothuru S, Chan WC, Ranka S, <i>et al<\/i>. Epidemiology and outcomes of hypertensive crisis in patients with chronic kidney disease: a nationwide analysis. J Hypertens 2022; 40: 1288-93.","DOI":"10.1097\/HJH.0000000000003136"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Luke RG. Hypertensive nephrosclerosis. Kidney Int 2006; 70: 1383.","DOI":"10.1038\/sj.ki.5001697"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 2008; 17: 266-70.","DOI":"10.1097\/MNH.0b013e3282f88a1f"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mavrogeni S, Piaditis G, Bacopoulou F, <i>et al<\/i>. Cardiac Remodeling in Hypertension: Clinical Impact on Brain, Heart, and Kidney Function. Horm Metab Res 2022; 54: 273-9.","DOI":"10.1055\/a-1793-6134"},{"key":"26","first-page":"e840","volume":"139","year":"2019","unstructured":"26. Rangaswami J, Bhalla V, Blair JEA, <i>et al<\/i>. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 2019; 139: e840-78.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cerezo C, Ruilope LM, Segura J, <i>et al<\/i>. Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression. J Hypertens 2012; 30: 204-9.","DOI":"10.1097\/HJH.0b013e32834d9e0f"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chen C, Yang X, Lei Y, <i>et al<\/i>. Urinary Biomarkers at the Time of AKI Diagnosis as Predictors of Progression of AKI among Patients with Acute Cardiorenal Syndrome. Clin J Am Soc Nephrol 2016; 11: 1536-44.","DOI":"10.2215\/CJN.00910116"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/2\/67_25-515\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:49:08Z","timestamp":1775274548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/2\/67_25-515\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-515","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"25-515"}}